Wearable dermal sensor

- Biolinq Incorporated
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top plan view of a first embodiment of a wearable dermal sensor;

FIG. 2 is a bottom plan view thereof;

FIG. 3 is a side elevation view thereof;

FIG. 4 is a side elevation view thereof;

FIG. 5 is a rear elevation view thereof;

FIG. 6 is a front elevation view thereof;

FIG. 7 is a top perspective view thereof;

FIG. 8 is a perspective view showing the wearable dermal sensor worn by a user;

FIG. 9 is a top perspective of a second embodiment of a wearable dermal sensor illustrating a first portion illuminated; and,

FIG. 10 is a top perspective of a third embodiment of a wearable dermal sensor illustrating a first portion illuminated and a second portion illuminated.

The broken lines show unclaimed environment only and form no part of the claimed design.

Claims

The ornamental design for a wearable dermal sensor, as shown and described.

Referenced Cited
U.S. Patent Documents
4305401 December 15, 1981 Reissmueller et al.
4323996 April 6, 1982 Ganter
4407295 October 4, 1983 Steuer et al.
5131390 July 21, 1992 Sakaguchi
5279543 January 18, 1994 Glikfeld et al.
5286364 February 15, 1994 Yacynych et al.
5540828 July 30, 1996 Yacynych
5730714 March 24, 1998 Guy et al.
5766132 June 16, 1998 Yasukawa et al.
6036055 March 14, 2000 Mogadam et al.
6139718 October 31, 2000 Kurnik et al.
6269053 July 31, 2001 Kawata et al.
6284126 September 4, 2001 Kurnik et al.
6413396 July 2, 2002 Yang et al.
6471903 October 29, 2002 Sherman et al.
6603987 August 5, 2003 Whitson
6814845 November 9, 2004 Wilson et al.
6862466 March 1, 2005 Ackerman
6908453 June 21, 2005 Fleming
7097776 August 29, 2006 Raju
7132054 November 7, 2006 Kravitz et al.
7262068 August 28, 2007 Roy et al.
7343188 March 11, 2008 Sohrab
7344499 March 18, 2008 Prausnitz et al.
7429333 September 30, 2008 Chiou et al.
7456112 November 25, 2008 Lee
7493232 February 17, 2009 Surina
8022292 September 20, 2011 Arianpour et al.
8088321 January 3, 2012 Ferguson et al.
8094009 January 10, 2012 Allen et al.
8125331 February 28, 2012 Allen et al.
8130095 March 6, 2012 Allen et al.
8284046 October 9, 2012 Allen et al.
8574165 November 5, 2013 Marsh
8798799 August 5, 2014 Deo et al.
8909543 December 9, 2014 Tropper et al.
D722697 February 17, 2015 Moon
D750786 March 1, 2016 Davies et al.
D757000 May 24, 2016 Lagomarsino et al.
9551698 January 24, 2017 Huys et al.
9737247 August 22, 2017 Wang
9743870 August 29, 2017 Wang
D815289 April 10, 2018 Evers et al.
D816229 April 24, 2018 Frick et al.
9933387 April 3, 2018 McCanna et al.
D820988 June 19, 2018 Pushpala
10092207 October 9, 2018 Windmiller
10136846 November 27, 2018 Wang et al.
D842996 March 12, 2019 Frick et al.
D845289 April 9, 2019 Chuang
10251565 April 9, 2019 Chan
D867911 November 26, 2019 Alabdin
10492708 December 3, 2019 Windmiller
D875254 February 11, 2020 Cooke
D882432 April 28, 2020 Yee
10765369 September 8, 2020 Antonio
11045142 June 29, 2021 Windmiller et al.
11207025 December 28, 2021 Trapero Martin
20030225360 December 4, 2003 Eppstein
20060015061 January 19, 2006 Kuo et al.
20070170054 July 26, 2007 Wilsey
20070213044 September 13, 2007 Steingart et al.
20090088652 April 2, 2009 Tremblay
20090143761 June 4, 2009 Cantor
20090259118 October 15, 2009 Feldman et al.
20100056873 March 4, 2010 Allen et al.
20100286803 November 11, 2010 Tillotson
20120323097 December 20, 2012 Chowdhury
20130065257 March 14, 2013 Wang et al.
20130144131 June 6, 2013 Wang et al.
20140259652 September 18, 2014 Pushpala et al.
20140275897 September 18, 2014 Pushpala
20140336487 November 13, 2014 Wang et al.
20150335272 November 26, 2015 Natale et al.
20170055851 March 2, 2017 Al-Ali
20180249937 September 6, 2018 Wiese et al.
20190095602 March 28, 2019 Setlak et al.
20190125223 May 2, 2019 Wang et al.
20190167167 June 6, 2019 Mitchell et al.
20190309433 October 10, 2019 Sattayasamitsathit et al.
20200085341 March 19, 2020 Windmiller
20200101286 April 2, 2020 Windmiller et al.
20200214566 July 9, 2020 Allen et al.
20200254240 August 13, 2020 Windmiller et al.
20200297997 September 24, 2020 Windmiller et al.
20210187286 June 24, 2021 Windmiller et al.
20210393201 December 23, 2021 Morelock et al.
20220031209 February 3, 2022 Windmiller et al.
20220031244 February 3, 2022 Windmiller et al.
20220175278 June 9, 2022 Windmiller et al.
Foreign Patent Documents
WO-2009/034313 March 2009 WO
WO-2009/034313 March 2009 WO
WO-2009/064164 May 2009 WO
WO-2009/064164 May 2009 WO
WO-2010/120364 October 2010 WO
WO-2010/120364 October 2010 WO
WO-2012/020332 February 2012 WO
WO-2012/020332 February 2012 WO
WO-2013/058879 April 2013 WO
WO-2013/058879 April 2013 WO
Other references
  • Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using Insulin or not,” 3 pages.
  • American Diabetes Association® Press Release (2020). “American Diabetes Association ©Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
  • Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
  • Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
  • Biolinq, Inc. (2019), The Intelligent Continuous Glucose Monitoring System, 5 total pages.
  • Cao, J et al. (2017), “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
  • Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
  • Dexcom (2020). Analyst Day Presentation, 19 total pages.
  • Dexcom (2020). Analyst Day Presentation, 27 total pages.
  • Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021 ,” Diabetes Care 44(Supplement 1):S85-S99.
  • Fang, M. et al., (2021), “Trends in Diabetes Treatment and Control in U.S, Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
  • French, D.P. et al. (2008). “Original Article: Psychological Care Seif-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
  • Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range Indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24.
  • Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study),” J. Diab. Sci. Tech. 12:1211-1219.
  • Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
  • Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring with Glycemic Control and Acute Metabolic Events Among Patients with Insulin-Treated Diabetes,” JAMA 325:2273-2284.
  • Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin a Randomized Clinical Trial,” JAMA 325:2262-2272.
  • McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
  • Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography.” J. Biomed. Optics 9:274-281.
  • Non-Final Office Action dated Nov. 14, 2019. for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 10 pages.
  • Notice of Allowance dated Dec. 18, 2019, for U.S. Appl. No. 29/650,794, 63. filed Jun. 8, 2018, 7 pages.
  • Polonsky, W.H. et al. (2011), “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
  • Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
  • Sheikh, Z. et al. (2015). “Macrophages. Foreign Body Giant Celis and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
  • Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.
Patent History
Patent number: D988160
Type: Grant
Filed: Mar 16, 2021
Date of Patent: Jun 6, 2023
Assignee: Biolinq Incorporated (San Diego, CA)
Inventor: David Morelock (Escondido, CA)
Primary Examiner: Antoine Duval Davis
Application Number: 29/774,399